Correlation Between Esperion Therapeutics and CG Oncology,
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and CG Oncology, Common, you can compare the effects of market volatilities on Esperion Therapeutics and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and CG Oncology,.
Diversification Opportunities for Esperion Therapeutics and CG Oncology,
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Esperion and CGON is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and CG Oncology, go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and CG Oncology,
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.8 times more return on investment than CG Oncology,. However, Esperion Therapeutics is 1.8 times more volatile than CG Oncology, Common. It trades about 0.2 of its potential returns per unit of risk. CG Oncology, Common is currently generating about -0.02 per unit of risk. If you would invest 196.00 in Esperion Therapeutics on September 3, 2024 and sell it today you would earn a total of 84.00 from holding Esperion Therapeutics or generate 42.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. CG Oncology, Common
Performance |
| Timeline |
| Esperion Therapeutics |
| CG Oncology, Common |
Esperion Therapeutics and CG Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and CG Oncology,
The main advantage of trading using opposite Esperion Therapeutics and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| CG Oncology, vs. Paysafe | CG Oncology, vs. Sapiens International | CG Oncology, vs. VirnetX Holding Corp | CG Oncology, vs. Entravision Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |